Shareholders Equity: The sum of preferred and common equity items.
Niagen Bioscience, Inc. (NAGE) had Shareholders Equity of $83.07M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$27.19M |
|
$-1.17M |
|
$10.09M |
|
$17.11M |
|
$28.78M |
|
$-1.59M |
|
$0.41M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.17M |
|
$-1.59M |
|
$-1.30M |
|
79.15M |
|
79.15M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$100.22M |
|
$1.22M |
|
$8.48M |
|
$108.69M |
|
$16.91M |
|
-- |
|
$8.71M |
|
$25.62M |
|
$83.07M |
|
$77.94M |
|
|
Shareholders Equity |
$83.07M |
79.03M |
|
| Cash Flow Statement Financials | |
$4.20M |
|
$5.10M |
|
$-4.58M |
|
$64.79M |
|
$69.51M |
|
$4.72M |
|
$4.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.90% |
|
-5.84% |
|
-5.84% |
|
-- |
|
-4.31% |
|
-4.31% |
|
$9.30M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.49 |
|
3.98 |
|
22.64 |
|
-1.41% |
|
-1.50% |
|
-1.08% |
|
-1.41% |
|
$1.05 |
|
$0.12 |
|
$0.05 |
|